Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma
Status:
Terminated
Trial end date:
2017-07-13
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is learn if taking Femara (letrozole) after a
hysterectomy (surgical removal of the uterus) for uterine leiomyosarcoma will delay or
prevent the cancer from coming back.